1998
DOI: 10.1056/nejm199802123380701
|View full text |Cite
|
Sign up to set email alerts
|

A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein Thrombosis

Abstract: In high-risk patients with proximal deep-vein thrombosis, the initial beneficial effect of vena caval filters for the prevention of pulmonary embolism was counterbalanced by an excess of recurrent deep-vein thrombosis, without any difference in mortality. Our data also confirmed that low-molecular-weight heparin was as effective and safe as unfractionated heparin for the prevention of pulmonary embolism.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

13
736
6
31

Year Published

2000
2000
2016
2016

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 1,582 publications
(786 citation statements)
references
References 21 publications
13
736
6
31
Order By: Relevance
“…In this cohort of postarthroplasty patients, the incidence of major bleeding complications (10%) was substantially higher than the rates reported for nonsurgical patients, which are 0% to 5% [5,20,22,35]. This difference highlights the unique risks inherent to anticoagulation treatment in patients who have undergone procedures, which include substantial soft tissue dissection and osteotomies.…”
Section: Discussionmentioning
confidence: 62%
See 1 more Smart Citation
“…In this cohort of postarthroplasty patients, the incidence of major bleeding complications (10%) was substantially higher than the rates reported for nonsurgical patients, which are 0% to 5% [5,20,22,35]. This difference highlights the unique risks inherent to anticoagulation treatment in patients who have undergone procedures, which include substantial soft tissue dissection and osteotomies.…”
Section: Discussionmentioning
confidence: 62%
“…Because the risk of developing PE is greatest in close proximity to surgery, the treating surgeon is faced with starting aggressive, potent anticoagulation at a time when the risk of bleeding from the surgical site is highest [12]. Major surgical site bleeding increases the risk of neurologic damage [4,5] and reoperation [7], delays recovery [16,25], and increases the risk of infection by 12.3% [31]. Potentially fatal bleeding can also occur in other organ systems [19,29].…”
Section: Introductionmentioning
confidence: 99%
“…Inferior vena cava filter retrievals, standard and novel techniques showed a statistically significant increase in the incidence of lower-extremity deep venous thrombosis in patients in whom IVC filters were implanted as compared to control patients (8). Based upon these and other findings, the U.S. Food and Drug Administration (FDA) issued a safety alert in 2014 recommending IVC filter removal as soon as is clinically appropriate and shared the responsibility of filter removal equally between the implanting physician and the clinician responsible for the ongoing care of patients in whom a retrievable IVC filter has been placed (9).…”
Section: Review Articlementioning
confidence: 99%
“…Cardiovasc Diagn Ther 2016;6(6):642-650 cdt.amegroups.com loops such as the duodenum, aortic wall penetration, and small-bowel volvulus. Filter migration and spontaneous fracture and embolization of filter components have also been reported (8,10,14,27,28). Nonetheless, before using advanced techniques for IVC filter retrieval, the associated possible complications should always be compared to the potential risks of leaving the filter permanently indwelling, and should be individualized.…”
Section: Complications Of Ivc Filter Retrievalsmentioning
confidence: 99%
“…Complications associated with anticoagulation in the TJA population include bleeding, postoperative infection, a higher rate of blood product transfusion, and drug thrombocytopenia. Surgical site bleeding increases the risk of neurologic damage, infection, reoperation, and delays recovery [5,7,14,17,25,26]. Neviaser et al found that postoperative therapeutic enoxaparin treatment had a 10% rate of major and a 27% rate of minor bleeding complications in TJA patients [21].…”
Section: Discussionmentioning
confidence: 99%